Concord Wealth Partners Ishares Biotechnology ETF Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
A detailed history of Concord Wealth Partners transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Concord Wealth Partners holds 39 shares of IBB stock, worth $5,081. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 39
-0.0%
Holding current value
$5,081
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IBB
# of Institutions
1,018Shares Held
34.4MCall Options Held
5.4MPut Options Held
7.26M-
Bank Of America Corp Charlotte, NC7.49MShares$976 Million0.08% of portfolio
-
Morgan Stanley New York, NY3.48MShares$453 Million0.03% of portfolio
-
Jane Street Group, LLC New York, NY1.96MShares$255 Million0.06% of portfolio
-
Citigroup Inc1.86MShares$242 Million0.15% of portfolio
-
Royal Bank Of Canada Toronto, A61.21MShares$157 Million0.03% of portfolio